Publications

D. P. Funda, L. Palová-Jelínková, J. Goliáš, Z. Kroulíková, A. Fajstová, T. Hudcovic, R. Špíšek

Optimal Tolerogenic Dendritic Cells in Type 1 Diabetes (T1D) Therapy: What Can We Learn From Non-obese Diabetic (NOD) Mouse Models?

Front Immunol. 2019 May 14;10:967. doi: 10.3389/fimmu.2019.00967. eCollection 2019

J. Fucikova, J. Rakova, M. Hensler, L. Kasikova, L. Belicová, K. Hladikova, I. Truxova, P. Skapa, J. Laco, L. Pecen, I. Praznovec, M.J.Halaska, T. Brtnicky, R. Kodet, A. Fialová, J. Pineau, A. Gey, E. Tartour, A. Ryska, L. Galluzzi, R. Spisek.

TIM-3 Dictates Functional Orientation of the Immune Infiltrate in Ovarian Cancer.

Clin Cancer Res. 2019 May 10. pii: clincanres.4175.2018. doi: 10.1158/1078-0432.CCR-18-4175. [Epub ahead of print]

A. Grohová, K. Dáňová, R. Špíšek, L. Palová-Jelínková

Cell Based Therapy for Type 1 Diabetes: Should We Take Hyperglycemia Into Account?

Front Immunol. 2019 Feb 5;10:79. doi: 10.3389/fimmu.2019.00079. eCollection 2019.